Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Milrinone O-Glucuronide

● Auf Lager

Katalog-Nr.::	VE0025675
CAS-Nr.::	N/A
Summenformel::	C18H17N3O7
Molare Masse::	387.34 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu

Parent drug

Milrinone

IUPAC-Name

(2R,3R,4R,5S,6R)-6-((5-cyano-2-methyl-[3,4′-bipyridin]-6-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

SMILES

O=C([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC2=C(C#N)C=C(C3=CC=NC=C3)C(C)=N2)O1)O

InChI

InChI=1S/C18H17N3O7/c1-8-11(9-2-4-20-5-3-9)6-10(7-19)16(21-8)28-18-14(24)12(22)13(23)15(27-18)17(25)26/h2-6,12-15,18,22-24H,1H3,(H,25,26)/t12-,13-,14+,15-,18-/m1/s1

Beschreibung

Milrinone O-Glucuronide impurity is a primary glucuronide metabolite and degradation product observed during milrinone synthesis and stability testing. Thorough analytical characterization using LC-MS, LC-MS/MS and high resolution HPLC facilitates identification, structure confirmation and quantification in API and formulated drug substance. Control strategy should include validated chromatographic methods, reference standard qualification and forced degradation studies to define formation pathways and acceptable limits under ICH guidelines. Understanding its physicochemical properties, retention behavior, and potential impact on pharmacokinetics and safety supports impurity profiling, specification setting and regulatory submissions. Timely monitoring during process development and stability studies reduces risk of out of specification events.